» Articles » PMID: 31861118

Pseudoxanthoma Elasticum, Kidney Stones and Pyrophosphate: From a Rare Disease to Urolithiasis and Vascular Calcifications

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Dec 22
PMID 31861118
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudoxanthoma elasticum is a rare disease mainly due to gene mutations and characterized by ectopic biomineralization and fragmentation of elastic fibers resulting in skin, cardiovascular and retinal calcifications. It has been recently described that pyrophosphate (a calcification inhibitor) deficiency could be the main cause of ectopic calcifications in this disease and in other genetic disorders associated to mutations of or . Patients affected by Pseudoxanthoma Elasticum seem also prone to develop kidney stones originating from papillary calcifications named Randall's plaque, and to a lesser extent may be affected by nephrocalcinosis. In this narrative review, we summarize some recent discoveries relative to the pathophysiology of this mendelian disease responsible for both cardiovascular and renal papillary calcifications, and we discuss the potential implications of pyrophosphate deficiency as a promoter of vascular calcifications in kidney stone formers and in patients affected by chronic kidney disease.

Citing Articles

The PROPHECI trial: a phase II, double-blind, placebo-controlled, randomized clinical trial for the treatment of pseudoxanthoma elasticum with oral pyrophosphate.

Clotaire L, Rubera I, Duranton C, Gal J, Chamorey E, Humeau H Trials. 2025; 26(1):30.

PMID: 39881395 PMC: 11776210. DOI: 10.1186/s13063-024-08666-w.


A high-calcium environment induced ectopic calcification of renal interstitial fibroblasts via TFPI-2-DCHS1-ALP/ENPP1 axis to participate in Randall's plaque formation.

Liu M, Liu Z, Huang F, Chen H, Yang Z, Zhu Z Urolithiasis. 2024; 52(1):122.

PMID: 39196305 DOI: 10.1007/s00240-024-01622-y.


Cell death‑related molecules and targets in the progression of urolithiasis (Review).

Wu L, Xue X, He C, Lai Y, Tong L Int J Mol Med. 2024; 53(6).

PMID: 38666544 PMC: 11090264. DOI: 10.3892/ijmm.2024.5376.


The Purinergic Nature of Pseudoxanthoma Elasticum.

Kauffenstein G, Martin L, Le Saux O Biology (Basel). 2024; 13(2).

PMID: 38392293 PMC: 10886499. DOI: 10.3390/biology13020074.


Bone Marrow-Derived ABCC6 Is an Essential Regulator of Ectopic Calcification In Pseudoxanthoma Elasticum.

Brampton C, Pomozi V, Le Corre Y, Zoll J, Kauffenstein G, Ma C J Invest Dermatol. 2024; 144(8):1772-1783.e3.

PMID: 38367909 PMC: 11260544. DOI: 10.1016/j.jid.2024.01.026.


References
1.
Pomozi V, Julian C, Zoll J, Pham K, Kuo S, Tokesi N . Dietary Pyrophosphate Modulates Calcification in a Mouse Model of Pseudoxanthoma Elasticum: Implication for Treatment of Patients. J Invest Dermatol. 2018; 139(5):1082-1088. PMC: 6478508. DOI: 10.1016/j.jid.2018.10.040. View

2.
Nitschke Y, Baujat G, Botschen U, Wittkampf T, du Moulin M, Stella J . Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet. 2012; 90(1):25-39. PMC: 3257960. DOI: 10.1016/j.ajhg.2011.11.020. View

3.
Nitschke Y, Rutsch F . Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts. Curr Osteoporos Rep. 2017; 15(4):255-270. DOI: 10.1007/s11914-017-0370-3. View

4.
Letavernier E, Kauffenstein G, Huguet L, Navasiolava N, Bouderlique E, Tang E . ABCC6 Deficiency Promotes Development of Randall Plaque. J Am Soc Nephrol. 2018; 29(9):2337-2347. PMC: 6115671. DOI: 10.1681/ASN.2017101148. View

5.
Germain D, Boutouyrie P, Laloux B, Laurent S . Arterial remodeling and stiffness in patients with pseudoxanthoma elasticum. Arterioscler Thromb Vasc Biol. 2003; 23(5):836-41. DOI: 10.1161/01.ATV.0000067428.19031.28. View